Item 5. Market for Registrant’s Common Equity
Item
5. Market for Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market
Information
Our
common stock is quoted on the OTCQB under the symbol “SUND.” There is no “established trading market” for our
shares of common stock. No assurance can be given that any established trading market for our common stock will develop or be maintained,
and if an established trading market develops in the future, the sale of shares of our common stock that are deemed to be “restricted
securities” or “control securities” pursuant to Rule 144 of the SEC by members of management or others may have a substantial
adverse impact on any such market.
Holders
As
of June 29, 2026, we had 126 stockholders of record and an indeterminate number of stockholders who held shares in “street
name.”
Dividends
There
are no present material restrictions that limit our ability to pay dividends on our common or preferred stock. Presently, we have no
plans to pay dividends in the foreseeable future. Our Board of Directors intends to pursue a policy of retaining earnings, if any, for
use in our operations and to finance the expansion of our business. Any declaration and payment of dividends in the future, of which
there can be no assurance, will be determined by our Board of Directors in light of existing conditions, including our earnings, financial
condition, capital requirements and other factors. There are presently no dividends which are accrued or owing with respect to our outstanding
common stock. No assurance can be given that dividends will ever be declared or paid on our common stock in the future.
24
Recent
Sales of Unregistered Securities
During
the year ended March 31, 2026, the Company issued 1,664,550 warrants to the Chairman of the Board of Directors, 2,687,705 warrants
to Radiant Life, LLC, and 1,166,000 warrants to Mr. Dickman in conjunction with various extensions of maturity dates during the
period (see Note 8). The exercise price of these warrants was $0.41. The value of the warrants on the date of grant, as calculated
by the Black-Scholes-Merton valuation model was $242,791, $576,773, and $170,404, respectively. The inputs used in this calculation
included a fair value of the underlying common stock between $0.25 and $0.409 per share, a risk-free rate between 3.72% and 3.81%,
volatility between 81.93% and 82.79%, and a dividend rate of 0%.
On
December 09, 2025 the Company issued 17,378 warrants to Radiant Life, LLC in conjunction with monies borrowed (see Note 8). The exercise
price of these warrants was $0.41. The value of the warrants on the date of grant, as calculated by the Black-Scholes-Merton valuation
model, was $4,777. The inputs used in this calculation included a fair value of $0.409 per share, a risk-free rate of 3.78%, volatility
of 81.58% and a dividend rate of 0%.
During
the year ended March 31, 2025, the Company issued 1,544,550 warrants to the Chairman of the Board of Directors in conjunction with an
extension of the maturity dates of certain debt instruments. The exercise price of these warrants was $0.41 per share. The value of the
warrants on the date of grant, as calculated by the Black-Scholes-Merton valuation model was $435,199. The valuation inputs included
a fair value of the underlying common stock of $0.409 per share, a risk-free interest rate of 4.43%, an expected volatility of 83.74%
and a dividend yield of 0%.
From
June 18, 2024, to July 10, 2024, the Company received subscription agreements from investors, for 805,000 common shares at a purchase
price of $1 per share, including 1,610,000 warrants exercisable at $0.35 per share, vested immediately upon issuance, with a five year
expiration. Proceeds to the company totaled $805,000.
These
securities were issued in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506
of Regulation D.
Purchases
of Equity Securities by Us and Affiliated Purchasers
None.
Item
6. [Reserved.]